Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2026

Institutional positions in Amicus Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

FOLD is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026

Institutional holders
0
−2 vs. Q2 2026
Shares held
0
−797 (−100.0%) vs. Q2 2026
Total value
$0
−$11.5K (−100.0%) vs. Q2 2026
New holders
0
0 more added
Sold out
2
0 more reduced

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 0 institutions
Q1 2021: 259 institutionsQ2 2021: 235 institutionsQ3 2021: 238 institutionsQ4 2021: 224 institutionsQ1 2022: 216 institutionsQ2 2022: 213 institutionsQ3 2022: 222 institutionsQ4 2022: 230 institutionsQ1 2023: 226 institutionsQ2 2023: 216 institutionsQ3 2023: 229 institutionsQ4 2023: 229 institutionsQ1 2024: 254 institutionsQ2 2024: 259 institutionsQ3 2024: 295 institutionsQ4 2024: 292 institutionsQ1 2025: 286 institutionsQ2 2025: 272 institutionsQ3 2025: 288 institutionsQ4 2025: 334 institutionsQ1 2026: 298 institutionsQ2 2026: 2 institutionsQ3 2026: 0 institutions
Value heldQ3 2026: $0
Q1 2021: $2.74BQ2 2021: $2.67BQ3 2021: $2.80BQ4 2021: $3.48BQ1 2022: $2.87BQ2 2022: $3.28BQ3 2022: $3.05BQ4 2022: $3.57BQ1 2023: $3.30BQ2 2023: $3.86BQ3 2023: $3.63BQ4 2023: $4.53BQ1 2024: $3.79BQ2 2024: $3.13BQ3 2024: $3.31BQ4 2024: $2.88BQ1 2025: $2.55BQ2 2025: $1.83BQ3 2025: $2.47BQ4 2025: $4.57BQ1 2026: $4.81BQ2 2026: $11.5KQ3 2026: $0
Institutions holding FOLD and their total value by quarter
QuarterHoldersValue
Q3 20260$0
Q2 20262$11.5K
Q1 2026298$4.81B
Q4 2025334$4.57B
Q3 2025288$2.47B
Q2 2025272$1.83B
Q1 2025286$2.55B
Q4 2024292$2.88B
Q3 2024295$3.31B
Q2 2024259$3.13B
Q1 2024254$3.79B
Q4 2023229$4.53B
Q3 2023229$3.63B
Q2 2023216$3.86B
Q1 2023226$3.30B
Q4 2022230$3.57B
Q3 2022222$3.05B
Q2 2022213$3.28B
Q1 2022216$2.87B
Q4 2021224$3.48B
Q3 2021238$2.80B
Q2 2021235$2.67B
Q1 2021259$2.74B

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding FOLD in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
IFP Advisors, Inc0$00.00%−796−100.0%Sold out
Huntington National Bank0$00.00%−1−100.0%Sold out